BERGENBIO ASA (BGBIO.OL) Stock Earnings & Estimates
Europe - OSL:BGBIO - NO0013251173 - Common Stock
1.196 NOK
+0.01 (+0.67%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 389K -49.74% | 354K -9.00% | 848K 139.55% | -100.00% | 19.167M | |||
| EBITDA YoY % growth | -304.752M 2.68% | -191.596M 37.13% | -150.778M 21.30% | -108.15M 28.27% | -225.57M -108.57% | -1.03M 99.54% | -462.673M -44,819.75% | |
| EBIT YoY % growth | -305.635M 2.81% | -191.819M 37.24% | -151.234M 21.16% | -109.18M 27.81% | -226.6M -107.55% | -1.03M 99.55% | -339.157M -32,827.82% | |
| Operating Margin | -78,569.41% | -54,186.16% | -17,834.20% | N/A | N/A | N/A | -1,769.48% | |
| EPS YoY % growth | -0.39 88.92% | N/A -3,980.82% | -3.75 76.51% | -3.09 17.60% | -6.46 -109.00% | -6.07 6.08% | -6.66 -9.84% |
All data in NOK
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in NOK
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.73 63.50% | -1.12 | 0.39 | 34.98% |
| Q3 2024 Q2Q % growth | -0.63 37.00% | -1.38 | 0.75 | 54.35% |
| Q2 2024 Q2Q % growth | -1.39 | -1.29 | -0.10 | -7.96% |
| Q1 2024 Q2Q % growth | -1.00 | -2.06 | 1.06 | 51.46% |
| Q4 2023 Q2Q % growth | -2.00 -1,903.81% | -1.03 | -0.97 | -94.17% |
| Q3 2023 Q2Q % growth | -1.00 -1,200.90% | -2.06 | 1.06 | 51.46% |
| Q4 2022 Q2Q % growth | -0.10 87.20% | -0.10 | 0.00 | 0.63% |
| Q3 2022 Q2Q % growth | -0.08 90.39% | -0.10 | 0.02 | 20.67% |
| Q2 2022 Q2Q % growth | -0.11 89.31% | -0.10 | -0.01 | -11.12% |
| Q1 2022 Q2Q % growth | -0.11 88.65% | -0.09 | -0.01 | -14.51% |
| Q4 2021 Q2Q % growth | -0.78 8.24% | -0.83 | 0.05 | 6.51% |
| Q3 2021 Q2Q % growth | -0.80 -3.90% | -1.06 | 0.26 | 24.59% |
| Q2 2021 Q2Q % growth | -1.02 -18.60% | -0.97 | -0.05 | -5.35% |
| Q1 2021 Q2Q % growth | -0.93 -27.40% | -0.83 | -0.10 | -12.16% |
| Q4 2020 Q2Q % growth | -0.85 9.31% | -0.80 | -0.05 | -5.80% |
| Q3 2020 Q2Q % growth | -0.77 -6.03% | -0.72 | -0.05 | -6.80% |
| Q2 2020 Q2Q % growth | -0.86 9.00% | -0.67 | -0.19 | -28.45% |
| Q1 2020 Q2Q % growth | -0.73 9.40% | -0.82 | 0.09 | 11.15% |
| Q4 2019 Q2Q % growth | -0.94 | -1.66 | 0.72 | 43.54% |
| Q3 2019 Q2Q % growth | -0.73 | -1.32 | 0.59 | 44.85% |
| Q2 2019 Q2Q % growth | -0.95 | -1.00 | 0.05 | 5.40% |
| Q1 2019 Q2Q % growth | -0.81 | -0.98 | 0.18 | 18.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 681K 92.37% | 681K | % | |
| Q4 2023 Q2Q % growth | 354K -9.00% | 354K | % | |
| Q4 2022 Q2Q % growth | 389K -49.74% | 389K | % | |
| Q4 2021 Q2Q % growth | 774K 28.79% | 774K | % | |
| Q4 2020 Q2Q % growth | 601K 175.69% | 601K | % | |
| Q1 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2019 Q2Q % growth | 2.06M | -2.06M | -100.00% | |
| Q1 2019 Q2Q % growth | 8.682M | 3.09M | 5.592M | 180.97% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |